

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin catabolic process (GO:0009111) | 4.53714731 |
| 2 | fat-soluble vitamin catabolic process (GO:0042363) | 4.53714731 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33467616 |
| 4 | regulation of memory T cell differentiation (GO:0043380) | 4.15273596 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04065432 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.04065432 |
| 7 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.48690016 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48092822 |
| 9 | signal peptide processing (GO:0006465) | 3.40761740 |
| 10 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.36780406 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.33939735 |
| 12 | negative regulation of T cell mediated immunity (GO:0002710) | 3.28601668 |
| 13 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27800723 |
| 14 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.27723962 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 3.26695883 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.25040910 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19481724 |
| 18 | cellular extravasation (GO:0045123) | 3.12877670 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12505471 |
| 20 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.06428202 |
| 21 | T-helper 1 type immune response (GO:0042088) | 3.06266233 |
| 22 | positive regulation of interleukin-17 production (GO:0032740) | 3.02029160 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00391739 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.98702383 |
| 25 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.98224563 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 2.98078144 |
| 27 | tryptophan metabolic process (GO:0006568) | 2.92182635 |
| 28 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.92058803 |
| 29 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.89720900 |
| 30 | regulation of T-helper 1 type immune response (GO:0002825) | 2.87074919 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 2.86416356 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 2.86416356 |
| 33 | tryptophan catabolic process (GO:0006569) | 2.86416356 |
| 34 | negative regulation of complement activation (GO:0045916) | 2.84866590 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83932880 |
| 36 | regulation of regulatory T cell differentiation (GO:0045589) | 2.81094546 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 2.80729670 |
| 38 | establishment of protein localization to Golgi (GO:0072600) | 2.80057993 |
| 39 | positive regulation of type 2 immune response (GO:0002830) | 2.79780411 |
| 40 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.79592408 |
| 41 | protein targeting to Golgi (GO:0000042) | 2.79101179 |
| 42 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.77635163 |
| 43 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74596528 |
| 44 | neutrophil mediated immunity (GO:0002446) | 2.74440706 |
| 45 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.72624925 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.72624925 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.71649830 |
| 48 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.69161205 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 2.68924584 |
| 50 | activated T cell proliferation (GO:0050798) | 2.68658584 |
| 51 | cell wall macromolecule metabolic process (GO:0044036) | 2.67552376 |
| 52 | response to interleukin-15 (GO:0070672) | 2.67288111 |
| 53 | cell wall macromolecule catabolic process (GO:0016998) | 2.64982430 |
| 54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.64489297 |
| 55 | cellular response to exogenous dsRNA (GO:0071360) | 2.63595732 |
| 56 | positive regulation of defense response to virus by host (GO:0002230) | 2.62803075 |
| 57 | negative regulation of adaptive immune response (GO:0002820) | 2.62573880 |
| 58 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61461724 |
| 59 | valine metabolic process (GO:0006573) | 2.58619552 |
| 60 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.55453550 |
| 61 | negative T cell selection (GO:0043383) | 2.54649333 |
| 62 | positive regulation of natural killer cell activation (GO:0032816) | 2.54222604 |
| 63 | neural crest cell development (GO:0014032) | 2.53830704 |
| 64 | negative thymic T cell selection (GO:0045060) | 2.53561133 |
| 65 | regulation of interleukin-17 production (GO:0032660) | 2.53501755 |
| 66 | retinoic acid metabolic process (GO:0042573) | 2.52537220 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 2.51954544 |
| 68 | dendritic cell migration (GO:0036336) | 2.51804732 |
| 69 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.51632756 |
| 70 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.50671258 |
| 71 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.50656408 |
| 72 | aromatic amino acid family catabolic process (GO:0009074) | 2.50395889 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 2.49847423 |
| 74 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49553063 |
| 75 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.49230374 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48785509 |
| 77 | positive regulation of interferon-alpha production (GO:0032727) | 2.48672776 |
| 78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48071307 |
| 79 | regulation of cell killing (GO:0031341) | 2.47188970 |
| 80 | negative regulation of humoral immune response (GO:0002921) | 2.46146205 |
| 81 | regulation of T-helper cell differentiation (GO:0045622) | 2.45168979 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 2.40811579 |
| 83 | detection of bacterium (GO:0016045) | 2.40533606 |
| 84 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.39404613 |
| 85 | negative regulation of lipid storage (GO:0010888) | 2.39238727 |
| 86 | regulation of protein glycosylation (GO:0060049) | 2.38768073 |
| 87 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.37927687 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.37484135 |
| 89 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.37484135 |
| 90 | regulation of T cell mediated immunity (GO:0002709) | 2.37360255 |
| 91 | regulation of activation of Janus kinase activity (GO:0010533) | 2.37354868 |
| 92 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.37336058 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36799750 |
| 94 | positive regulation of T cell mediated immunity (GO:0002711) | 2.36402873 |
| 95 | detection of external biotic stimulus (GO:0098581) | 2.35100391 |
| 96 | neutrophil activation (GO:0042119) | 2.34999866 |
| 97 | positive regulation of cell killing (GO:0031343) | 2.34589093 |
| 98 | microglial cell activation (GO:0001774) | 2.34279959 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34024124 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 2.34024124 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34024124 |
| 102 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.34024124 |
| 103 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34024124 |
| 104 | modulation by symbiont of host immune response (GO:0052553) | 2.34024124 |
| 105 | positive regulation of T cell cytokine production (GO:0002726) | 2.33985776 |
| 106 | amyloid precursor protein catabolic process (GO:0042987) | 2.32913884 |
| 107 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.32872774 |
| 108 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.31179852 |
| 109 | growth hormone receptor signaling pathway (GO:0060396) | 2.30645651 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.30555124 |
| 111 | cellular response to type I interferon (GO:0071357) | 2.30555124 |
| 112 | response to type I interferon (GO:0034340) | 2.30461759 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.29872324 |
| 114 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.29622003 |
| 115 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.29033336 |
| 116 | phagocytosis, recognition (GO:0006910) | 2.27945049 |
| 117 | cranial suture morphogenesis (GO:0060363) | 2.26034333 |
| 118 | granulocyte activation (GO:0036230) | 2.22257263 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.19864909 |
| 120 | cellular biogenic amine catabolic process (GO:0042402) | 2.19515805 |
| 121 | amine catabolic process (GO:0009310) | 2.19515805 |
| 122 | detection of other organism (GO:0098543) | 2.15965248 |
| 123 | kynurenine metabolic process (GO:0070189) | 2.14701463 |
| 124 | positive regulation of antigen processing and presentation (GO:0002579) | 2.12839640 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.10746190 |
| 126 | macrophage activation involved in immune response (GO:0002281) | 2.09860157 |
| 127 | cellular response to growth hormone stimulus (GO:0071378) | 2.09756520 |
| 128 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.09184468 |
| 129 | fatty acid beta-oxidation (GO:0006635) | 2.08776811 |
| 130 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.08776236 |
| 131 | positive regulation of cholesterol efflux (GO:0010875) | 2.08582661 |
| 132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.08424234 |
| 133 | L-phenylalanine catabolic process (GO:0006559) | 2.08424234 |
| 134 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.08144501 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.07421079 |
| 136 | regulation of hexokinase activity (GO:1903299) | 2.07160517 |
| 137 | regulation of glucokinase activity (GO:0033131) | 2.07160517 |
| 138 | phospholipid efflux (GO:0033700) | 2.06608079 |
| 139 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.06365170 |
| 140 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.04863072 |
| 141 | indolalkylamine metabolic process (GO:0006586) | 2.04532646 |
| 142 | negative regulation of mast cell activation (GO:0033004) | 2.04212621 |
| 143 | positive regulation of sterol transport (GO:0032373) | 2.03561565 |
| 144 | positive regulation of cholesterol transport (GO:0032376) | 2.03561565 |
| 145 | regulation of cholesterol storage (GO:0010885) | 2.03293598 |
| 146 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.03231662 |
| 147 | mesenchymal cell development (GO:0014031) | 2.03165619 |
| 148 | dendritic cell chemotaxis (GO:0002407) | 2.01263825 |
| 149 | toxin transport (GO:1901998) | 1.99543522 |
| 150 | diterpenoid biosynthetic process (GO:0016102) | 1.98235598 |
| 151 | regulation of interleukin-8 secretion (GO:2000482) | 1.97859234 |
| 152 | detection of biotic stimulus (GO:0009595) | 1.97759505 |
| 153 | interferon-gamma production (GO:0032609) | 1.97031064 |
| 154 | positive regulation of interleukin-12 production (GO:0032735) | 1.95827297 |
| 155 | protein carboxylation (GO:0018214) | 1.95662802 |
| 156 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.95662802 |
| 157 | NIK/NF-kappaB signaling (GO:0038061) | 1.95314533 |
| 158 | negative regulation of viral genome replication (GO:0045071) | 1.94529398 |
| 159 | response to peptidoglycan (GO:0032494) | 1.94457801 |
| 160 | positive regulation of T cell migration (GO:2000406) | 1.94380036 |
| 161 | myeloid dendritic cell activation (GO:0001773) | 1.93985884 |
| 162 | Golgi transport vesicle coating (GO:0048200) | 1.93081705 |
| 163 | COPI coating of Golgi vesicle (GO:0048205) | 1.93081705 |
| 164 | gland morphogenesis (GO:0022612) | 1.92003203 |
| 165 | myoblast migration (GO:0051451) | 1.90983381 |
| 166 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 1.90846482 |
| 167 | phosphate ion homeostasis (GO:0055062) | 1.90814230 |
| 168 | trivalent inorganic anion homeostasis (GO:0072506) | 1.90814230 |
| 169 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.90671634 |
| 170 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 1.89340665 |
| 171 | positive regulation of monocyte chemotaxis (GO:0090026) | 1.89111885 |
| 172 | regulation of RIG-I signaling pathway (GO:0039535) | 1.88889961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.06792939 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.49479287 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38434664 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.25007677 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15573731 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.05685821 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88092907 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78310146 |
| 9 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.56622946 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.38748189 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31338090 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29697131 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.29236402 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27115519 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18289649 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.14883249 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.13356012 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13331769 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13072935 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.11018287 |
| 21 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.09351425 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04162944 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03216708 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01544937 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99896663 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96448512 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88239950 |
| 28 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86205551 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81713539 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77660562 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76180950 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73941936 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68985559 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68404473 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68404381 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67970746 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.65896493 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65801559 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57899346 |
| 40 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57690485 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56033163 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52829960 |
| 43 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.49696720 |
| 44 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48168670 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47934129 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46850182 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45553940 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.45111969 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43286907 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42083697 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41719606 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41467619 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38609641 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38281545 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.37977015 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37971648 |
| 57 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36885740 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34343964 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33657158 |
| 60 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33223364 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32335269 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31629162 |
| 63 | * MYB_26560356_Chip-Seq_TH2_Human | 1.30652248 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29705041 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29226853 |
| 66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28077366 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26458826 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24521824 |
| 69 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23251435 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20059802 |
| 71 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19860034 |
| 72 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19743163 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18403813 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17707014 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17343442 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15828272 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15102072 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14843230 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14820863 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14295987 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13845903 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13090468 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12462573 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11596276 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11135451 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09912309 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09699227 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09155209 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09103126 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08461668 |
| 91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08461668 |
| 92 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.07315120 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07262171 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07260537 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07260537 |
| 96 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06411751 |
| 97 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.05893614 |
| 98 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.05819913 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05428401 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05409560 |
| 101 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05203876 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04783197 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04527428 |
| 104 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03239568 |
| 105 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03239568 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02578273 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02516854 |
| 108 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.01423205 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01309765 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00564552 |
| 111 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00113036 |
| 112 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99931086 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99566927 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99450763 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99370420 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98985594 |
| 117 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.98655028 |
| 118 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98503329 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98503329 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98164668 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.97877722 |
| 122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97839068 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97717222 |
| 124 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97044940 |
| 125 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.96933752 |
| 126 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96831058 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96743930 |
| 128 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96480234 |
| 129 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96165981 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96088676 |
| 131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95589652 |
| 132 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94811633 |
| 133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94166252 |
| 134 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.94037270 |
| 135 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93565192 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93558492 |
| 137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93408730 |
| 138 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93194435 |
| 139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91362614 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91241472 |
| 141 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90517301 |
| 142 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.90135299 |
| 143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90088647 |
| 144 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90025098 |
| 145 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89933032 |
| 146 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89665854 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89649691 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.89441516 |
| 149 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88963438 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88847725 |
| 151 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.88771970 |
| 152 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87988987 |
| 153 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87897809 |
| 154 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87496522 |
| 155 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86786002 |
| 156 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86673177 |
| 157 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.83315865 |
| 158 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82910349 |
| 159 | MAF_26560356_Chip-Seq_TH1_Human | 0.81019725 |
| 160 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80728723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 2.88449174 |
| 2 | MP0003303_peritoneal_inflammation | 2.57737823 |
| 3 | MP0002009_preneoplasia | 2.43795835 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.40670757 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.33860783 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.21942630 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.18080393 |
| 8 | MP0009785_altered_susceptibility_to | 2.05756535 |
| 9 | MP0003724_increased_susceptibility_to | 1.98496471 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 1.89106511 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 1.86038796 |
| 12 | MP0002166_altered_tumor_susceptibility | 1.85642669 |
| 13 | MP0005365_abnormal_bile_salt | 1.78971271 |
| 14 | MP0001545_abnormal_hematopoietic_system | 1.76919546 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 1.76919546 |
| 16 | MP0008004_abnormal_stomach_pH | 1.74740675 |
| 17 | MP0003941_abnormal_skin_development | 1.69912878 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 1.68355424 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.67019026 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 1.65706620 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 1.62371315 |
| 22 | MP0002132_abnormal_respiratory_system | 1.62298781 |
| 23 | MP0002419_abnormal_innate_immunity | 1.61753361 |
| 24 | MP0000685_abnormal_immune_system | 1.58916577 |
| 25 | MP0003195_calcinosis | 1.56722730 |
| 26 | MP0005387_immune_system_phenotype | 1.56585036 |
| 27 | MP0001790_abnormal_immune_system | 1.56585036 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.55833120 |
| 29 | MP0005671_abnormal_response_to | 1.55809528 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.54938269 |
| 31 | MP0002006_tumorigenesis | 1.54867937 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.51291235 |
| 33 | MP0001879_abnormal_lymphatic_vessel | 1.48420624 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.48205169 |
| 35 | MP0003787_abnormal_imprinting | 1.47330282 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.46877022 |
| 37 | MP0005025_abnormal_response_to | 1.46588244 |
| 38 | MP0008260_abnormal_autophagy | 1.46437713 |
| 39 | MP0003436_decreased_susceptibility_to | 1.45410414 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.41175940 |
| 41 | MP0005360_urolithiasis | 1.38117820 |
| 42 | MP0004484_altered_response_of | 1.37189605 |
| 43 | MP0001853_heart_inflammation | 1.36787621 |
| 44 | MP0002254_reproductive_system_inflammat | 1.35999380 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.31619616 |
| 46 | MP0005164_abnormal_response_to | 1.30755128 |
| 47 | MP0009764_decreased_sensitivity_to | 1.30400688 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.28920933 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.28189569 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.26354563 |
| 51 | MP0001800_abnormal_humoral_immune | 1.26251651 |
| 52 | MP0003646_muscle_fatigue | 1.26123709 |
| 53 | MP0002405_respiratory_system_inflammati | 1.24269799 |
| 54 | MP0002723_abnormal_immune_serum | 1.22477419 |
| 55 | MP0003186_abnormal_redox_activity | 1.20493697 |
| 56 | MP0004883_abnormal_blood_vessel | 1.18445087 |
| 57 | MP0003828_pulmonary_edema | 1.18405126 |
| 58 | MP0001819_abnormal_immune_cell | 1.15336419 |
| 59 | MP0005275_abnormal_skin_tensile | 1.14925031 |
| 60 | MP0003943_abnormal_hepatobiliary_system | 1.14607843 |
| 61 | MP0006054_spinal_hemorrhage | 1.14288599 |
| 62 | MP0002098_abnormal_vibrissa_morphology | 1.13458953 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.13224608 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.13077477 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.12907162 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.12803104 |
| 67 | MP0005410_abnormal_fertilization | 1.11357695 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 1.10315781 |
| 69 | MP0000383_abnormal_hair_follicle | 1.10064597 |
| 70 | MP0006082_CNS_inflammation | 1.08602217 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.07447467 |
| 72 | MP0002933_joint_inflammation | 1.06181860 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.05333826 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.04381558 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.04208853 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.02570405 |
| 77 | MP0005408_hypopigmentation | 1.01567758 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.00470466 |
| 79 | MP0002060_abnormal_skin_morphology | 0.99162094 |
| 80 | MP0009840_abnormal_foam_cell | 0.98988692 |
| 81 | MP0004947_skin_inflammation | 0.96918414 |
| 82 | MP0008469_abnormal_protein_level | 0.96662715 |
| 83 | MP0005503_abnormal_tendon_morphology | 0.95614351 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.92859897 |
| 85 | MP0003252_abnormal_bile_duct | 0.92340368 |
| 86 | MP0004381_abnormal_hair_follicle | 0.91714963 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.90667676 |
| 88 | MP0002168_other_aberrant_phenotype | 0.90647718 |
| 89 | MP0000716_abnormal_immune_system | 0.90156649 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.89992716 |
| 91 | MP0003448_altered_tumor_morphology | 0.89757234 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.89635016 |
| 93 | MP0003045_fibrosis | 0.89140391 |
| 94 | MP0005670_abnormal_white_adipose | 0.88417808 |
| 95 | MP0004147_increased_porphyrin_level | 0.87926124 |
| 96 | MP0000609_abnormal_liver_physiology | 0.87066967 |
| 97 | MP0001243_abnormal_dermal_layer | 0.86044018 |
| 98 | MP0008995_early_reproductive_senescence | 0.86008314 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.85157817 |
| 100 | MP0003866_abnormal_defecation | 0.85086365 |
| 101 | MP0005390_skeleton_phenotype | 0.84647296 |
| 102 | MP0000249_abnormal_blood_vessel | 0.84305068 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.81532489 |
| 104 | MP0002398_abnormal_bone_marrow | 0.80771022 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.79985872 |
| 106 | MP0000343_altered_response_to | 0.78848532 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.78699221 |
| 108 | MP0005166_decreased_susceptibility_to | 0.77985529 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.77460211 |
| 110 | MP0009763_increased_sensitivity_to | 0.76883670 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.76395543 |
| 112 | MP0005310_abnormal_salivary_gland | 0.76139813 |
| 113 | MP0009697_abnormal_copulation | 0.76115440 |
| 114 | MP0002938_white_spotting | 0.76055250 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.75861575 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75702539 |
| 117 | MP0001851_eye_inflammation | 0.75055821 |
| 118 | MP0009053_abnormal_anal_canal | 0.75044128 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.74695689 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.74490272 |
| 121 | MP0002429_abnormal_blood_cell | 0.74083260 |
| 122 | MP0009384_cardiac_valve_regurgitation | 0.73925151 |
| 123 | MP0003795_abnormal_bone_structure | 0.73905773 |
| 124 | MP0001764_abnormal_homeostasis | 0.73287227 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.72913495 |
| 126 | MP0001542_abnormal_bone_strength | 0.72158092 |
| 127 | MP0005508_abnormal_skeleton_morphology | 0.72106534 |
| 128 | MP0003011_delayed_dark_adaptation | 0.70940274 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.70771035 |
| 130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70669467 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.70238738 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.69672932 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.69389065 |
| 134 | MP0000858_altered_metastatic_potential | 0.69383799 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.68452980 |
| 136 | MP0000598_abnormal_liver_morphology | 0.68207003 |
| 137 | MP0000371_diluted_coat_color | 0.68137539 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.68065008 |
| 139 | MP0002722_abnormal_immune_system | 0.67752443 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.67504761 |
| 141 | MP0000516_abnormal_urinary_system | 0.67504761 |
| 142 | MP0005257_abnormal_intraocular_pressure | 0.66867315 |
| 143 | MP0000427_abnormal_hair_cycle | 0.66795988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.39915571 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 3.55288468 |
| 3 | Generalized aminoaciduria (HP:0002909) | 3.33324793 |
| 4 | T lymphocytopenia (HP:0005403) | 3.21880535 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.10610626 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07969090 |
| 7 | Myositis (HP:0100614) | 2.98818471 |
| 8 | Eczematoid dermatitis (HP:0000976) | 2.98104179 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 2.96610213 |
| 10 | Hemoptysis (HP:0002105) | 2.93653342 |
| 11 | Pulmonary infiltrates (HP:0002113) | 2.85310669 |
| 12 | Optic neuritis (HP:0100653) | 2.84156094 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 2.84156094 |
| 14 | Leukocytosis (HP:0001974) | 2.83434847 |
| 15 | Orchitis (HP:0100796) | 2.77747476 |
| 16 | Keratitis (HP:0000491) | 2.71908950 |
| 17 | Gangrene (HP:0100758) | 2.67124370 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 2.63689022 |
| 19 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.57715348 |
| 20 | Eosinophilia (HP:0001880) | 2.55833702 |
| 21 | Renal cortical cysts (HP:0000803) | 2.54168160 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53469439 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 2.49871771 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48495401 |
| 25 | Albinism (HP:0001022) | 2.46411306 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46141838 |
| 27 | Abnormality of T cells (HP:0002843) | 2.44467538 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.44397288 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.44111651 |
| 30 | Prolonged bleeding time (HP:0003010) | 2.43705404 |
| 31 | Hypoglycemic coma (HP:0001325) | 2.43510959 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.41787331 |
| 33 | Stomach cancer (HP:0012126) | 2.41767385 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 2.41373377 |
| 35 | Periodontitis (HP:0000704) | 2.41167966 |
| 36 | Polyneuropathy (HP:0001271) | 2.40793109 |
| 37 | Syringomyelia (HP:0003396) | 2.38438996 |
| 38 | Spinal cord lesions (HP:0100561) | 2.38438996 |
| 39 | Alveolar cell carcinoma (HP:0006519) | 2.37662669 |
| 40 | Abnormality of eosinophils (HP:0001879) | 2.36412811 |
| 41 | Anorexia (HP:0002039) | 2.36410461 |
| 42 | Facial diplegia (HP:0001349) | 2.34019213 |
| 43 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.32594653 |
| 44 | Pulmonary embolism (HP:0002204) | 2.32572907 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.27391316 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25774529 |
| 47 | Nausea (HP:0002018) | 2.24518386 |
| 48 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.24139165 |
| 49 | Prolonged neonatal jaundice (HP:0006579) | 2.23873377 |
| 50 | Thrombocytosis (HP:0001894) | 2.21519566 |
| 51 | Thyroiditis (HP:0100646) | 2.20796595 |
| 52 | Nonimmune hydrops fetalis (HP:0001790) | 2.20590767 |
| 53 | Meningitis (HP:0001287) | 2.19882690 |
| 54 | Pancreatic cysts (HP:0001737) | 2.18722100 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18203743 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18203743 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18203743 |
| 58 | Increased IgE level (HP:0003212) | 2.17090974 |
| 59 | IgG deficiency (HP:0004315) | 2.16067606 |
| 60 | Chronic hepatic failure (HP:0100626) | 2.15670207 |
| 61 | Prostate neoplasm (HP:0100787) | 2.14269171 |
| 62 | Granulocytopenia (HP:0001913) | 2.12964587 |
| 63 | Acne (HP:0001061) | 2.12886355 |
| 64 | Tubulointerstitial nephritis (HP:0001970) | 2.10365802 |
| 65 | Acute hepatic failure (HP:0006554) | 2.10048017 |
| 66 | Increased CSF protein (HP:0002922) | 2.09801876 |
| 67 | Neonatal hypoglycemia (HP:0001998) | 2.08950480 |
| 68 | Symptomatic seizures (HP:0011145) | 2.06627803 |
| 69 | Enlarged kidneys (HP:0000105) | 2.05819581 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05177746 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.04489932 |
| 72 | Myocardial infarction (HP:0001658) | 2.04086179 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.03584315 |
| 74 | Abnormality of T cell physiology (HP:0011840) | 2.03453755 |
| 75 | Recurrent skin infections (HP:0001581) | 2.03121568 |
| 76 | Abnormality of the intrinsic pathway (HP:0010989) | 2.03036317 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.02492109 |
| 78 | Vertigo (HP:0002321) | 2.01803583 |
| 79 | Peritonitis (HP:0002586) | 2.01676556 |
| 80 | Chest pain (HP:0100749) | 1.98135673 |
| 81 | Microcytic anemia (HP:0001935) | 1.96208894 |
| 82 | Complement deficiency (HP:0004431) | 1.95213739 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.93190338 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 1.93190338 |
| 85 | Gingivitis (HP:0000230) | 1.92625648 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92519632 |
| 87 | True hermaphroditism (HP:0010459) | 1.92145870 |
| 88 | Azoospermia (HP:0000027) | 1.92023494 |
| 89 | Arterial thrombosis (HP:0004420) | 1.90214066 |
| 90 | Epistaxis (HP:0000421) | 1.89889159 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 1.89490031 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89490031 |
| 93 | Hepatocellular carcinoma (HP:0001402) | 1.89272846 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 1.89153386 |
| 95 | Abnormality of macrophages (HP:0004311) | 1.87587472 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 1.87468999 |
| 97 | Steatorrhea (HP:0002570) | 1.87246533 |
| 98 | Glomerulonephritis (HP:0000099) | 1.85977857 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85530892 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85530892 |
| 101 | Patchy hypopigmentation of hair (HP:0011365) | 1.84877349 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 1.84782075 |
| 103 | Pustule (HP:0200039) | 1.84760071 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 1.84588879 |
| 105 | Joint hemorrhage (HP:0005261) | 1.83532745 |
| 106 | Fat malabsorption (HP:0002630) | 1.82588860 |
| 107 | Proximal tubulopathy (HP:0000114) | 1.81323592 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 1.79528311 |
| 109 | White forelock (HP:0002211) | 1.78258138 |
| 110 | Recurrent fungal infections (HP:0002841) | 1.77822613 |
| 111 | Recurrent bronchitis (HP:0002837) | 1.77628005 |
| 112 | Hypoproteinemia (HP:0003075) | 1.77575984 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 1.75271262 |
| 114 | Metaphyseal dysplasia (HP:0100255) | 1.75264206 |
| 115 | Gingival bleeding (HP:0000225) | 1.74102512 |
| 116 | Recurrent pneumonia (HP:0006532) | 1.73428762 |
| 117 | Encephalitis (HP:0002383) | 1.73400433 |
| 118 | Joint swelling (HP:0001386) | 1.73258025 |
| 119 | Gonadotropin excess (HP:0000837) | 1.72900979 |
| 120 | Thrombophlebitis (HP:0004418) | 1.72351844 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.71913001 |
| 122 | Chronic diarrhea (HP:0002028) | 1.71602302 |
| 123 | Type I transferrin isoform profile (HP:0003642) | 1.71528716 |
| 124 | Urticaria (HP:0001025) | 1.71075372 |
| 125 | Portal hypertension (HP:0001409) | 1.70544188 |
| 126 | Poikilocytosis (HP:0004447) | 1.69717600 |
| 127 | Recurrent viral infections (HP:0004429) | 1.68501721 |
| 128 | Disproportionate short-trunk short stature (HP:0003521) | 1.68390856 |
| 129 | Bile duct proliferation (HP:0001408) | 1.68386537 |
| 130 | Abnormal biliary tract physiology (HP:0012439) | 1.68386537 |
| 131 | Hepatosplenomegaly (HP:0001433) | 1.66939058 |
| 132 | Abnormal spermatogenesis (HP:0008669) | 1.66362938 |
| 133 | Osteomyelitis (HP:0002754) | 1.66249084 |
| 134 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.65083948 |
| 135 | Episodic fever (HP:0001954) | 1.64908129 |
| 136 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.64551695 |
| 137 | Glomerulopathy (HP:0100820) | 1.64449204 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64092162 |
| 139 | Pancreatitis (HP:0001733) | 1.63262325 |
| 140 | Increased IgM level (HP:0003496) | 1.62864080 |
| 141 | Abnormality of the hepatic vasculature (HP:0006707) | 1.62671398 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.62606998 |
| 143 | Abolished electroretinogram (ERG) (HP:0000550) | 1.62598989 |
| 144 | Type 2 muscle fiber atrophy (HP:0003554) | 1.62399069 |
| 145 | Hypoglycemic seizures (HP:0002173) | 1.61705847 |
| 146 | Abnormality of nucleobase metabolism (HP:0010932) | 1.61581619 |
| 147 | Acute myeloid leukemia (HP:0004808) | 1.61475253 |
| 148 | Abnormality of the endocardium (HP:0004306) | 1.61043295 |
| 149 | Neoplasm of the liver (HP:0002896) | 1.60793362 |
| 150 | Hyperuricemia (HP:0002149) | 1.59170873 |
| 151 | Increased purine levels (HP:0004368) | 1.59170873 |
| 152 | Intestinal atresia (HP:0011100) | 1.57605489 |
| 153 | Elevated alkaline phosphatase (HP:0003155) | 1.57306343 |
| 154 | Abnormality of the common coagulation pathway (HP:0010990) | 1.57184512 |
| 155 | Lip pit (HP:0100267) | 1.57110151 |
| 156 | Hematochezia (HP:0002573) | 1.56824212 |
| 157 | Hyperglycemia (HP:0003074) | 1.55957763 |
| 158 | Xanthomatosis (HP:0000991) | 1.55495786 |
| 159 | Bell-shaped thorax (HP:0001591) | 1.55416822 |
| 160 | Vertebral compression fractures (HP:0002953) | 1.51559326 |
| 161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.51298139 |
| 162 | Vasculitis (HP:0002633) | 1.51199463 |
| 163 | Tubulointerstitial fibrosis (HP:0005576) | 1.50926226 |
| 164 | Cerebral palsy (HP:0100021) | 1.49308747 |
| 165 | Pulmonary artery stenosis (HP:0004415) | 1.49096940 |
| 166 | Nephritis (HP:0000123) | 1.48452985 |
| 167 | Abnormality of complement system (HP:0005339) | 1.47970723 |
| 168 | Abnormality of T cell number (HP:0011839) | 1.47597284 |
| 169 | Petechiae (HP:0000967) | 1.47184424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 2.63557894 |
| 2 | NEK9 | 2.49870174 |
| 3 | IRAK3 | 2.45553611 |
| 4 | TYK2 | 2.43938789 |
| 5 | ZAK | 2.43338206 |
| 6 | SIK3 | 2.37648308 |
| 7 | IRAK4 | 2.29944881 |
| 8 | MAP4K2 | 2.28107762 |
| 9 | EPHA3 | 2.14176593 |
| 10 | TXK | 2.11310591 |
| 11 | NUAK1 | 2.09283819 |
| 12 | INSRR | 2.08076332 |
| 13 | ACVR1B | 1.91919933 |
| 14 | BCKDK | 1.84347761 |
| 15 | TRIM28 | 1.81837887 |
| 16 | TGFBR2 | 1.80195819 |
| 17 | FLT3 | 1.78466581 |
| 18 | BMPR1B | 1.72589950 |
| 19 | IKBKE | 1.70071347 |
| 20 | CHUK | 1.62656523 |
| 21 | TBK1 | 1.61531429 |
| 22 | IKBKB | 1.57278753 |
| 23 | FRK | 1.56365988 |
| 24 | TGFBR1 | 1.56257843 |
| 25 | TAOK3 | 1.55875927 |
| 26 | FES | 1.54001313 |
| 27 | MAP3K12 | 1.53889178 |
| 28 | PBK | 1.45065382 |
| 29 | FGFR4 | 1.44920298 |
| 30 | MAP4K1 | 1.44495754 |
| 31 | FER | 1.43904503 |
| 32 | LATS1 | 1.43772420 |
| 33 | AKT3 | 1.39482104 |
| 34 | CAMKK2 | 1.36572976 |
| 35 | TIE1 | 1.35839608 |
| 36 | RPS6KA4 | 1.34537178 |
| 37 | HCK | 1.34153222 |
| 38 | PIK3CG | 1.32645329 |
| 39 | BRSK2 | 1.31899735 |
| 40 | TEC | 1.28992548 |
| 41 | STK24 | 1.28912417 |
| 42 | GRK1 | 1.28141349 |
| 43 | JAK3 | 1.27378209 |
| 44 | NLK | 1.23832797 |
| 45 | KIT | 1.23190356 |
| 46 | MAP3K3 | 1.19749547 |
| 47 | EPHB1 | 1.17494698 |
| 48 | TRPM7 | 1.16780301 |
| 49 | MST1R | 1.16599835 |
| 50 | RIPK4 | 1.15726444 |
| 51 | STK3 | 1.13592654 |
| 52 | ERBB3 | 1.12561296 |
| 53 | SYK | 1.08593035 |
| 54 | GRK7 | 1.08426849 |
| 55 | STK38L | 1.06979379 |
| 56 | GRK6 | 1.06696159 |
| 57 | IRAK1 | 1.06245675 |
| 58 | NEK6 | 1.05817067 |
| 59 | ZAP70 | 1.04624564 |
| 60 | BTK | 1.01509863 |
| 61 | JAK1 | 1.01288515 |
| 62 | DYRK1B | 1.01067276 |
| 63 | PIM1 | 0.97835757 |
| 64 | PIK3CA | 0.97545907 |
| 65 | STK4 | 0.96636348 |
| 66 | MET | 0.92944271 |
| 67 | PTK2B | 0.91808154 |
| 68 | PRKCQ | 0.89901464 |
| 69 | ERN1 | 0.89260413 |
| 70 | TNK2 | 0.88159285 |
| 71 | CLK1 | 0.86664717 |
| 72 | LMTK2 | 0.85070668 |
| 73 | PAK3 | 0.84505087 |
| 74 | PDK2 | 0.82687238 |
| 75 | MAP3K5 | 0.81306431 |
| 76 | EIF2AK3 | 0.81265146 |
| 77 | FGR | 0.80032075 |
| 78 | ITK | 0.79877522 |
| 79 | YES1 | 0.79459951 |
| 80 | KDR | 0.77560783 |
| 81 | MAP3K1 | 0.77283251 |
| 82 | PASK | 0.76655106 |
| 83 | CSK | 0.74649468 |
| 84 | EIF2AK2 | 0.73963069 |
| 85 | OBSCN | 0.73289369 |
| 86 | PINK1 | 0.72762236 |
| 87 | FGFR3 | 0.71645750 |
| 88 | RAF1 | 0.71611306 |
| 89 | STK16 | 0.71027781 |
| 90 | CSF1R | 0.70194312 |
| 91 | MAPK7 | 0.69020091 |
| 92 | SIK1 | 0.68769599 |
| 93 | MST4 | 0.67146004 |
| 94 | CDK9 | 0.67101723 |
| 95 | BMPR2 | 0.66358095 |
| 96 | DYRK3 | 0.65492946 |
| 97 | MAP3K2 | 0.64997024 |
| 98 | RPS6KA5 | 0.64646469 |
| 99 | BRD4 | 0.62615622 |
| 100 | MAPK15 | 0.59522118 |
| 101 | HIPK2 | 0.59202370 |
| 102 | RPS6KA6 | 0.57532316 |
| 103 | LYN | 0.56886265 |
| 104 | IRAK2 | 0.56859123 |
| 105 | PIM2 | 0.56580983 |
| 106 | BCR | 0.55854740 |
| 107 | MYLK | 0.55737711 |
| 108 | SGK3 | 0.55447249 |
| 109 | SGK2 | 0.53825459 |
| 110 | CDK6 | 0.53474511 |
| 111 | MARK3 | 0.53240233 |
| 112 | ABL1 | 0.51896968 |
| 113 | BLK | 0.50500997 |
| 114 | KSR1 | 0.49904236 |
| 115 | LCK | 0.49685201 |
| 116 | STK38 | 0.48795759 |
| 117 | PRKAA2 | 0.48649449 |
| 118 | OXSR1 | 0.47293290 |
| 119 | MATK | 0.46215711 |
| 120 | CDK8 | 0.46198749 |
| 121 | MAP2K3 | 0.46101243 |
| 122 | PRKCE | 0.45704249 |
| 123 | IGF1R | 0.42126288 |
| 124 | MKNK1 | 0.42123277 |
| 125 | STK10 | 0.42100306 |
| 126 | EGFR | 0.41503456 |
| 127 | MELK | 0.40746699 |
| 128 | ADRBK2 | 0.40670230 |
| 129 | PLK2 | 0.38990560 |
| 130 | EIF2AK1 | 0.38543973 |
| 131 | PTK6 | 0.38324771 |
| 132 | MAPKAPK2 | 0.37622850 |
| 133 | RPS6KC1 | 0.37379352 |
| 134 | RPS6KL1 | 0.37379352 |
| 135 | JAK2 | 0.37237411 |
| 136 | EPHA2 | 0.37119458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11471100 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86443382 |
| 3 | Protein export_Homo sapiens_hsa03060 | 1.84638451 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84450232 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 1.84064662 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80935228 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78792481 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68254121 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68181833 |
| 10 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.67523313 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61593360 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57752596 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57151805 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56854537 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.53711093 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.53436551 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.51984670 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51914453 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51587509 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.51083650 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50615011 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.41843542 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.40826848 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39917326 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39132585 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37621555 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34681204 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33284839 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32617679 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30268041 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25703161 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25485101 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24078711 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23641676 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23080665 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19344288 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18503857 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.18342286 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.18232145 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.17981522 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15682642 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13823184 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11799598 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09129853 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08511799 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07081676 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07072587 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05903234 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05683216 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.05437248 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05256108 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01689019 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.01571822 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01053905 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.00838332 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97823897 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97336343 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97208853 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96699636 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95898473 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95382708 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94215216 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94036079 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93899144 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93494785 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93494227 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93267086 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92611961 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92271156 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91867373 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90925175 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90652210 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.90113233 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89755290 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86730376 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85054096 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84814366 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84462712 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83835594 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83217547 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81559156 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81516536 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.80770809 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.80278493 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79034080 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78760728 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76973870 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.76338224 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73117554 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.71600716 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70811692 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69971963 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67253945 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67113097 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66586664 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66432402 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66372022 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66146807 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65403093 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65073587 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64395242 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64221706 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.63393542 |
| 104 | RNA polymerase_Homo sapiens_hsa03020 | 0.63305876 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63077736 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62963047 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.62425424 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61333792 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.60787842 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60785813 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60031954 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59617291 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59390931 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58777846 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57961225 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55772515 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54926741 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54569815 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.54239830 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54229922 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.54016145 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52467682 |
| 123 | Mismatch repair_Homo sapiens_hsa03430 | 0.50423476 |
| 124 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50221285 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49738782 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.48819945 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.48499191 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.48032958 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.47436139 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46587076 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45765521 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45627694 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45005643 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.44605222 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.42554072 |
| 136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40461181 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39428714 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38324534 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37089447 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36165122 |

